Clinical Weight Loss Digest

GLP-1 Medication Updates

• 🔥 Semaglutide vs. Tirzepatide: Semaglutide is a single GLP-1 receptor agonist while tirzepatide is a dual GIP/GLP-1...

Updated ACSM resistance training guidelines, first in 17 years, emphasize sustainability for muscle benefits—ideal for weight loss practitioners.

-...

Key insight: Women struggle with body composition despite good eating—prioritize gut microbiome with fiber-first nutrition.

Practical tactics:

• Base...

• Superior efficacy: Tirzepatide achieves 15-21% body weight loss (Surmount-1 trial, 72 weeks) vs semaglutide's 15% (STEP-1, 68 weeks).
• Dual...

Key strategies for mitigating lean mass loss in women over 40:

• Strength training yields large effects on muscle mass, strength, and function in 50+...

Dr. Boz explains keto's edge in rapidly reducing insulin to unlock fat burning:

• Minimizes insulin spikes for efficient stored fat access; low-carb...

Key governance hurdles for triple-agonist incretins like retatrutide:

• Institutional shifts: Medication-centered care disrupts hospitals' procedure...

• Hidden sensitivities trigger immune dysregulation and inflammation, stalling metabolic progress.
• Clinical case study: Testing identifies dietary...

Emerging protocol trend: Combine calorie tweaks, movement boosts, and quick reboots for sustainable habit recovery.

• Small calorie balance...

Clinical Treatment Advances

• 🔥 Bimagrumab + Semaglutide Trial: A phase 2 trial found greater weight loss with combined bimagrumab and...

• Carb Loading Myth Busted: Keto adaptation enables fat burning over glycogen for endurance athletes, rethinking performance fuel.
• Metabolic...

Key evidence-based critiques to counter misinformation:

• Calories first: Energy balance prevents obesity and chronic disease far more than sugar vs....

Clinical studies reviewed show berberine users lost an average 4.4 pounds (2kg) more than controls—a realistic benchmark for clinicians managing expectations amid supplement hype.

Elevated cortisol drives abdominal fat storage and stalls fat loss by breaking down muscle, spiking cravings, and disrupting sleep.

Key behavioral...

Key trends from YRBS data (85k+ students):

• Prevalence up: 13.7% (2013) to 15.9% (2023), peaking at 16.3%; 11th graders hit 17.3%.
• Highest risks:...

Top evidence-based discoveries for professionals guiding clients:

• Calorie quality trumps quantity: Protein boosts metabolism and satiety.
• Gut...

Dual therapy with bimagrumab and semaglutide achieved greater weight loss than either alone in a phase 2 trial. This combo boosts GLP-1 efficacy, opening doors for advanced clinical fat loss strategies.

• Precise study answers if you can eat sugar and get shredded
• Ties into higher carbohydrate diets gaining popularity for long-term sustainable fat loss
• Program offers customized nutrition to break fat loss plateaus with lifelong education

Rising trend of 'natural GLP-1 alternatives' like berberine and patches fuels misinformation:

• Berberine touted for metabolic effects, but efficacy...

• Scale stalls, but clothes fit better, strength rises, and others notice—true recomposition at work
• Body recomposition beats weight chasing: lose...